IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9872877 B1

PDFFull Text
Date of Patent:
Jan. 23, 2018

Filed:

Jul. 06, 2016

Methods of using regenerative cells to promote epithelialization or neodermis formation

Applicant:

Cytori Therapeutics, Inc., San Diego, CA (US);

Inventors:

John K. Fraser, San Diego, CA (US);

Marc H. Hedrick, Solana Beach, CA (US);

Eric Daniels, San Diego, CA (US);

Assignee:

Cytori Therapeutics, Inc., San Diego, CA (US);

Attorney:

Knobbe Martens Olson & Bear LLP

Primary Examiner:

Blaine Lankford

Int. Cl.
CPC ...
A61M 1/00 (2006.01); A61K 35/28 (2015.01); A61K 35/12 (2015.01); C12N 5/0775 (2010.01); C12N 5/071 (2010.01); A61K 35/36 (2015.01); A61K 35/44 (2015.01); A61K 38/18 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 35/35 (2015.01); A61L 15/40 (2006.01); A61L 15/44 (2006.01); A61L 27/36 (2006.01); A61L 27/54 (2006.01); A61L 27/38 (2006.01); A61L 27/56 (2006.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); A61K 9/0014 (2013.01); A61K 35/12 (2013.01); A61K 35/35 (2013.01); A61K 35/36 (2013.01); A61K 35/44 (2013.01); A61K 38/1866 (2013.01); A61K 45/06 (2013.01); A61L 15/40 (2013.01); A61L 15/44 (2013.01); A61L 27/3604 (2013.01); A61L 27/3834 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); C12N 5/069 (2013.01); C12N 5/0667 (2013.01); A61L 2300/412 (2013.01); A61L 2300/64 (2013.01); C12N 2506/1384 (2013.01);
Abstract

Cells present in adipose tissue are used to promote wound healing in a patient. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the regenerative cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, cells present in adipose tissue are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic benefit.

Find Patent Forward Citations

Loading…